Stockreport

Generation Bio Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms at the ASGCT 27th Annual Meeting [Yahoo! Finance]

Generation Bio Co. - Common stock  (GBIO) 
PDF Rapid enzymatic synthesis continues to improve iqDNA performance through process development and the identification of novel structural elements Data on cell-targeted [Read more]